Pubblicazioni

Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: Long-term Results of a Prospective Phase II Study

2025 - CLINICAL ONCOLOGY

De Felice, F; Archetti, L; D'Ambrosio, G; Iafrate, F; Picone, V; M Magliocca, F; Musio, D; Roberto, M; Casella, G; Clementi, I; Bulzonetti, N; Picchetto, A; Vitti, E; Merenda, E; Gentili, C; Lanzilao, M; Miccini, M; Illuminati, G; Delle Donne, A; Crocetti, D; Minozzi, M; Mongardini, M; Caronna, R; Fiori, E; Cortesi, E

Neoadjuvant Therapy for Rectal Cancer: Updates From the UNICANCER-PRODIGE 23 Trial

2022 - CLINICAL COLORECTAL CANCER

Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis

2022 - ANTICANCER RESEARCH

DE Felice, Francesca; Musio, Daniela; Iafrate, Franco; Caponnetto, Salvatore; Picone, Vincenzo; D'Ambrosio, Giancarlo; Magliocca, Fabio Massimo; Tozzi, Francesca; DE Toma, Giorgio; Tombolini, Vincenzo; Cortesi, Enrico

Neoadjuvant therapy for rectal cancer: updates from the UNICANCER-PRODIGE 23 trial

2022 - CLINICAL COLORECTAL CANCER

De Felice, Francesca; Musio, Daniela; Tombolini, Vincenzo; Cortesi, Enrico

5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance

2022 - FRONTIERS IN ONCOLOGY

Pelullo, Maria; Zema, Sabrina; De Carolis, Mariangela; Cialfi, Samantha; Giuli, Maria Valeria; Palermo, Rocco; Capalbo, Carlo; Giannini, Giuseppe; Screpanti, Isabella; Checquolo, Saula; Bellavia, Diana

Intensified total neoadjuvant therapy in patients with locally advanced rectal cancer: a phase II trial

2021 - CLINICAL ONCOLOGY

De Felice, F.; D'Ambrosio, G.; Iafrate, F.; Gelibter, A.; Magliocca, F. M.; Musio, D.; Caponetto, S.; Casella, G.; Clementi, I.; Picchetto, A.; Sirgiovani, G.; Parisi, M.; Orciuoli, C.; Torrese, G.; De Toma, G.; Tombolini, V.; Cortesi, E.

S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens

2021 - CHEMOTHERAPY

Onorato, A.; Napolitano, A.; Spoto, S.; Incorvaia, L.; Russo, A.; Santini, D.; Tonini, G.; Vincenzi, B.

Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer

2019 - SURGICAL ONCOLOGY

Petrioli, Roberto; Marrelli, Daniele; Roviello, Franco; D'Ignazio, Alessia; Torre, Pamela; Chirra, Martina; Savelli, Vinno; Ambrosio, Maria Raffaella; Francini, Guido; Calomino, Natale; Farsi, Marco; Vernillo, Remo; Francini, Edoardo

Adjuvant chemotherapy in resected colon cancer: when, how and how long?

2019 - SURGICAL ONCOLOGY

Gelibter, A. J.; Caponnetto, S.; Urbano, F.; Emiliani, A.; Scagnoli, S.; Sirgiovanni, G.; Napoli, V. M.; Cortesi, E.

Tolerability of oxaliplatin-based neoadjuvant chemoradiotherapy in elderly locally advanced rectal cancer patients: a case-control study of a real-life experience

2019 - ANTICANCER RESEARCH

De Felice, F.; Siniscalchi, B.; Bulzonetti, N.; Caiazzo, R.; Musio, D.; Tombolini, V.

Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes

2018 - CLINICAL COLORECTAL CANCER

De Felice, Francesca; Llange, Karen; Rubini, Filippo; Bulzonetti, Nadia; Caiazzo, Rossella; Musio, Daniela; Tombolini, Vincenzo

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer

2017 - BMC CANCER

De Felice, Francesca; Benevento, Ilaria; Magnante, Anna Lisa; Musio, Daniela; Bulzonetti, Nadia; Caiazzo, Rossella; Tombolini, Vincenzo

Disease control, survival, and toxicity outcome after intensified neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a single-institution experience

2016 - CLINICAL COLORECTAL CANCER

De Felice, Francesca; Musio, Daniela; Magnante, Anna Lisa; Bulzonetti, Nadia; Benevento, Ilaria; Caiazzo, Rossella; Tombolini, Vincenzo

Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer. A single-institution experience

2015 - CANCER CHEMOTHERAPY AND PHARMACOLOGY

Petrioli, R; Francini, E; Roviello, F; Marrelli, D; Fiaschi, Ai; Laera, L; Rossi, G; Bianco, V; Brozzetti, Stefania; Roviello, G.